With the analysis among 256 patents, we discovered top 129 key players by total patent application. Aurigene Discovery Technologies Ltd., Merck & Co., Inc., Abbott Laboratories are dominant in this area. They take 14.06% of the total patent filing.
Aurigene Discovery Technologies Ltd.
Karnataka, India
Patent: 15
New Jersey, United States
Patent: 11
Illinois, United States
Patent: 10
Basel-Stadt, Switzerland
Patent: 8
Bridge Pharmaceuticals, Inc.
Yeda Research & Development Co. Ltd.
Washington, United States
Patent: 6
Molecular Targeting Technologies, Inc.
Pennsylvania, United States
Patent: 6
The Research Foundation of The State University of New York
New York, United States
Patent: 6
The General Hospital Corp.
Massachusetts, United States
Patent: 5
With the analysis among 15 patents, we discovered top 10 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Hibercell, Inc., NantOmics LLC are active in this area.
Institut National de la Santé et de la Recherche Médicale
New York, United States
Patent: 3
California, United States
Patent: 1
North Carolina, United States
Patent: 1
California, United States
Patent: 1
California, United States
Patent: 1
Pennsylvania, United States
Patent: 1
LISCure Bioscience Co. Ltd.
Corvidia Therapeutics, Inc.
Massachusetts, United States
Patent: 1
With the analysis among related 95 patents applied in the last 5 years. We discover 65 most active companies in this area. The fast-growing Bridge Pharmaceuticals, Inc., Molecular Targeting Technologies, Inc., The Research Foundation of The State University of New York take 21.05% of patent filing during this period.
Bridge Pharmaceuticals, Inc.
Molecular Targeting Technologies, Inc.
Pennsylvania, United States
Patent: 6
The Research Foundation of The State University of New York
New York, United States
Patent: 6
Connecticut, United States
Patent: 6
The Board of Regents of The University of Texas System
Texas, United States
Patent: 5
Shanghai Ennovabio Pharmaceuticals Co. Ltd.
Shanghai Shi, China
Patent: 3
Washington, United States
Patent: 2
Washington, United States
Patent: 2
Centre National De La Recherche Scientif
With the analysis among related 95 patents in last 5 years, we discover 52 new entrants. Bridge Pharmaceuticals, Inc., Molecular Targeting Technologies, Inc., The Research Foundation of The State University of New York are the most active new entrants in this area.
Bridge Pharmaceuticals, Inc.
Molecular Targeting Technologies, Inc.
Pennsylvania, United States
Patent: 6
The Research Foundation of The State University of New York
New York, United States
Patent: 6
Shanghai Ennovabio Pharmaceuticals Co. Ltd.
Shanghai Shi, China
Patent: 3
Washington, United States
Patent: 2
Centre National De La Recherche Scientif
Zhongshan Hospital Fudan University
Shanghai Shi, China
Patent: 1
Heilongjiang Sheng, China
Patent: 1
Ruijin Hospital Affiliated to Shanghai Jiaotong University Medical College
undefined undefined
Patent: 1
With the analysis among 91 patents, we discovered top 32 universities and scientific research institutions by total patent application. Yale University, The University of Chicago, Northwestern University are dominant in this area. They take 20.88% of the total patent filing.
Connecticut, United States
Patent: 7
The University of Chicago
Illinois, United States
Patent: 4
Illinois, United States
Patent: 3
The Royal Veterinary College
Chinese Academy of Medical Scciences & Peking Union Medical College
Washington, United States
Patent: 2
Virginia Commonwealth University
Virginia, United States
Patent: 2
Shanghai Shi, China
Patent: 2
Huazhong University of Science & Technology
Hubei Sheng, China
Patent: 2
New York, United States
Patent: 1